Source: GlobeNewswire

Press Release: Centrexion Therapeutics : Centrexion Therapeutics to Present New Positive Clinical Trial Results on Streamlined CNTX-4975 Administration Techniques

-- Administration procedure designed to optimize physician and patient experience and convenience -- -- Company also shares interim analysis of 719 patients in VICTORY-3 Phase 3 open-label trial indicating the studied streamlined administration procedures maintain patient comfort --

Read full article ยป
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Jeffrey B. Kindler's photo - CEO of Centrexion

CEO

Jeffrey B. Kindler

CEO Approval Rating

90/100

Read more